aluates Reports

$ 0.0

Automative

Oral Rotavirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-29F12010

Global Oral Rotavirus Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Oral Rotavirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29F12010

Report

September 2024

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Sanofi Pasteur

Merck

Biological E Limited

China National Biotec Group

SINOVAC BIOTECH

Oral Rotavirus Vaccine - Market Size

The global market for Oral Rotavirus Vaccine was estimated to be worth US$ 7215 million in 2023 and is forecast to a readjusted size of US$ 14890 million by 2030 with a CAGR of 12.8% during the forecast period 2024-2030

Oral Rotavirus Vaccine - Market

An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Rotavirus Vaccine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oral Rotavirus Vaccine by region & country, by Type, and by Application.

The Oral Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rotavirus Vaccine.

Market Segmentation

Scope of Oral Rotavirus Vaccine - Market Report

Report Metric	Details
Report Name	Oral Rotavirus Vaccine - Market
Forecasted market size in 2030	US$ 14890 million
CAGR	12.8%
Forecasted years	2024 - 2030
Segment by Type:	Rotarix RotaTeq Rotavac Rotavin-M1 Lanzhou lamb
Segment by Application	Hospital Vaccination Station Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Rotavirus Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oral Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oral Rotavirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Oral Rotavirus Vaccine - Market size in 2030?

Ans: The Oral Rotavirus Vaccine - Market size in 2030 will be US$ 14890 million.

Who are the main players in the Oral Rotavirus Vaccine - Market report?

Ans: The main players in the Oral Rotavirus Vaccine - Market are GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech

What are the Application segmentation covered in the Oral Rotavirus Vaccine - Market report?

Ans: The Applications covered in the Oral Rotavirus Vaccine - Market report are Hospital, Vaccination Station, Other

What are the Type segmentation covered in the Oral Rotavirus Vaccine - Market report?

Ans: The Types covered in the Oral Rotavirus Vaccine - Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb

Recommended Reports

Oral Vaccines Market

General Vaccines

Immunization Products

1 Market Overview

1.1 Oral Rotavirus Vaccine Product Introduction

1.2 Global Oral Rotavirus Vaccine Market Size Forecast

1.3 Oral Rotavirus Vaccine Market Trends & Drivers

1.3.1 Oral Rotavirus Vaccine Industry Trends

1.3.2 Oral Rotavirus Vaccine Market Drivers & Opportunity

1.3.3 Oral Rotavirus Vaccine Market Challenges

1.3.4 Oral Rotavirus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Oral Rotavirus Vaccine Players Revenue Ranking (2023)

2.2 Global Oral Rotavirus Vaccine Revenue by Company (2019-2024)

2.3 Key Companies Oral Rotavirus Vaccine Manufacturing Base Distribution and Headquarters

2.4 Key Companies Oral Rotavirus Vaccine Product Offered

2.5 Key Companies Time to Begin Mass Production of Oral Rotavirus Vaccine

2.6 Oral Rotavirus Vaccine Market Competitive Analysis

2.6.1 Oral Rotavirus Vaccine Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Oral Rotavirus Vaccine Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rotavirus Vaccine as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Rotarix

3.1.2 RotaTeq

3.1.3 Rotavac

3.1.4 Rotavin-M1

3.1.5 Lanzhou lamb

3.2 Global Oral Rotavirus Vaccine Sales Value by Type

3.2.1 Global Oral Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Oral Rotavirus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Oral Rotavirus Vaccine Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Vaccination Station

4.1.3 Other

4.2 Global Oral Rotavirus Vaccine Sales Value by Application

4.2.1 Global Oral Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Oral Rotavirus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Oral Rotavirus Vaccine Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Oral Rotavirus Vaccine Sales Value by Region

5.1.1 Global Oral Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Oral Rotavirus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Oral Rotavirus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Oral Rotavirus Vaccine Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Oral Rotavirus Vaccine Sales Value, 2019-2030

5.2.2 North America Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Oral Rotavirus Vaccine Sales Value, 2019-2030

5.3.2 Europe Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Oral Rotavirus Vaccine Sales Value, 2019-2030

5.4.2 Asia Pacific Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Oral Rotavirus Vaccine Sales Value, 2019-2030

5.5.2 South America Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Oral Rotavirus Vaccine Sales Value, 2019-2030

5.6.2 Middle East & Africa Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Oral Rotavirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Oral Rotavirus Vaccine Sales Value

6.3 United States

6.3.1 United States Oral Rotavirus Vaccine Sales Value, 2019-2030

6.3.2 United States Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Oral Rotavirus Vaccine Sales Value, 2019-2030

6.4.2 Europe Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Oral Rotavirus Vaccine Sales Value, 2019-2030

6.5.2 China Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Oral Rotavirus Vaccine Sales Value, 2019-2030

6.6.2 Japan Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Oral Rotavirus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Oral Rotavirus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Oral Rotavirus Vaccine Sales Value, 2019-2030

6.9.2 India Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Oral Rotavirus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GSK

7.1.1 GSK Profile

7.1.2 GSK Main Business

7.1.3 GSK Oral Rotavirus Vaccine Products, Services and Solutions

7.1.4 GSK Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.1.5 GSK Recent Developments

7.2 Sanofi-Pasteur

7.2.1 Sanofi-Pasteur Profile

7.2.2 Sanofi-Pasteur Main Business

7.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Products, Services and Solutions

7.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.2.5 Sanofi-Pasteur Recent Developments

7.3 Merck

7.3.1 Merck Profile

7.3.2 Merck Main Business

7.3.3 Merck Oral Rotavirus Vaccine Products, Services and Solutions

7.3.4 Merck Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.3.5 Biological E. Limited Recent Developments

7.4 Biological E. Limited

7.4.1 Biological E. Limited Profile

7.4.2 Biological E. Limited Main Business

7.4.3 Biological E. Limited Oral Rotavirus Vaccine Products, Services and Solutions

7.4.4 Biological E. Limited Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.4.5 Biological E. Limited Recent Developments

7.5 China National Biotec Group

7.5.1 China National Biotec Group Profile

7.5.2 China National Biotec Group Main Business

7.5.3 China National Biotec Group Oral Rotavirus Vaccine Products, Services and Solutions

7.5.4 China National Biotec Group Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.5.5 China National Biotec Group Recent Developments

7.6 Sinovac Biotech

7.6.1 Sinovac Biotech Profile

7.6.2 Sinovac Biotech Main Business

7.6.3 Sinovac Biotech Oral Rotavirus Vaccine Products, Services and Solutions

7.6.4 Sinovac Biotech Oral Rotavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.6.5 Sinovac Biotech Recent Developments

8 Industry Chain Analysis

8.1 Oral Rotavirus Vaccine Industrial Chain

8.2 Oral Rotavirus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Oral Rotavirus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Oral Rotavirus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Sanofi Pasteur

Merck

Biological E Limited

China National Biotec Group

SINOVAC BIOTECH

List of Tables

Table 1. Oral Rotavirus Vaccine Market Trends

Table 2. Oral Rotavirus Vaccine Market Drivers & Opportunity

Table 3. Oral Rotavirus Vaccine Market Challenges

Table 4. Oral Rotavirus Vaccine Market Restraints

Table 5. Global Oral Rotavirus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Oral Rotavirus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Oral Rotavirus Vaccine Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Oral Rotavirus Vaccine Product Type

Table 9. Key Companies Time to Begin Mass Production of Oral Rotavirus Vaccine

Table 10. Global Oral Rotavirus Vaccine Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rotavirus Vaccine as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Oral Rotavirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Oral Rotavirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Oral Rotavirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Oral Rotavirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Oral Rotavirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Oral Rotavirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Oral Rotavirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Oral Rotavirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Oral Rotavirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Oral Rotavirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Oral Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Oral Rotavirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Oral Rotavirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Oral Rotavirus Vaccine Sales Value by Region (2019-2024) & (%)

Table 27. Global Oral Rotavirus Vaccine Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Oral Rotavirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Oral Rotavirus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Oral Rotavirus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 31. GSK Basic Information List

Table 32. GSK Description and Business Overview

Table 33. GSK Oral Rotavirus Vaccine Products, Services and Solutions

Table 34. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of GSK (2019-2024)

Table 35. GSK Recent Developments

Table 36. Sanofi-Pasteur Basic Information List

Table 37. Sanofi-Pasteur Description and Business Overview

Table 38. Sanofi-Pasteur Oral Rotavirus Vaccine Products, Services and Solutions

Table 39. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of Sanofi-Pasteur (2019-2024)

Table 40. Sanofi-Pasteur Recent Developments

Table 41. Merck Basic Information List

Table 42. Merck Description and Business Overview

Table 43. Merck Oral Rotavirus Vaccine Products, Services and Solutions

Table 44. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of Merck (2019-2024)

Table 45. Merck Recent Developments

Table 46. Biological E. Limited Basic Information List

Table 47. Biological E. Limited Description and Business Overview

Table 48. Biological E. Limited Oral Rotavirus Vaccine Products, Services and Solutions

Table 49. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of Biological E. Limited (2019-2024)

Table 50. Biological E. Limited Recent Developments

Table 51. China National Biotec Group Basic Information List

Table 52. China National Biotec Group Description and Business Overview

Table 53. China National Biotec Group Oral Rotavirus Vaccine Products, Services and Solutions

Table 54. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of China National Biotec Group (2019-2024)

Table 55. China National Biotec Group Recent Developments

Table 56. Sinovac Biotech Basic Information List

Table 57. Sinovac Biotech Description and Business Overview

Table 58. Sinovac Biotech Oral Rotavirus Vaccine Products, Services and Solutions

Table 59. Revenue (US$ Million) in Oral Rotavirus Vaccine Business of Sinovac Biotech (2019-2024)

Table 60. Sinovac Biotech Recent Developments

Table 61. Key Raw Materials Lists

Table 62. Raw Materials Key Suppliers Lists

Table 63. Oral Rotavirus Vaccine Downstream Customers

Table 64. Oral Rotavirus Vaccine Distributors List

Table 65. Research Programs/Design for This Report

Table 66. Key Data Information from Secondary Sources

Table 67. Key Data Information from Primary Sources

Table 68. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Oral Rotavirus Vaccine Product Picture

Figure 2. Global Oral Rotavirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Oral Rotavirus Vaccine Report Years Considered

Figure 5. Global Oral Rotavirus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Rotavirus Vaccine Revenue in 2023

Figure 7. Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Rotarix Picture

Figure 9. RotaTeq Picture

Figure 10. Rotavac Picture

Figure 11. Rotavin-M1 Picture

Figure 12. Lanzhou lamb Picture

Figure 13. Global Oral Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Oral Rotavirus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Hospital

Figure 16. Product Picture of Vaccination Station

Figure 17. Product Picture of Other

Figure 18. Global Oral Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Oral Rotavirus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Oral Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Oral Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Oral Rotavirus Vaccine Sales Value (%), (2019-2030)

Figure 31. United States Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 37. China Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. China Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. India Oral Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Oral Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. India Oral Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Oral Rotavirus Vaccine Industrial Chain

Figure 53. Oral Rotavirus Vaccine Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rotavirus Vaccines Market Insights Forecast to 2030

Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024

Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024

Global Rotavirus Vaccine Market Research Report 2024

Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Delivery Vaccines Market Research Report 2025

Global Human Oral Vaccine Market Research Report 2024

Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccines for Aquatic Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Proteins and Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rotavirus Infection Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions